INDO US BIO-TECH | APIS INDIA. | INDO US BIO-TECH/ APIS INDIA. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 42.3 | 5.3 | 802.1% | View Chart |
P/BV | x | 8.6 | 1.0 | 909.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
INDO US BIO-TECH APIS INDIA. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO US BIO-TECH Mar-23 |
APIS INDIA. Mar-23 |
INDO US BIO-TECH/ APIS INDIA. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 125 | 64 | 194.9% | |
Low | Rs | 25 | 19 | 129.5% | |
Sales per share (Unadj.) | Rs | 61.6 | 602.5 | 10.2% | |
Earnings per share (Unadj.) | Rs | 7.2 | 13.4 | 54.0% | |
Cash flow per share (Unadj.) | Rs | 8.0 | 18.3 | 43.8% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 54.3 | 209.7 | 25.9% | |
Shares outstanding (eoy) | m | 10.03 | 5.51 | 182.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0.1 | 1,759.3% | |
Avg P/E ratio | x | 10.4 | 3.1 | 332.6% | |
P/CF ratio (eoy) | x | 9.4 | 2.3 | 410.0% | |
Price / Book Value ratio | x | 1.4 | 0.2 | 693.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 754 | 231 | 327.2% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 13 | 189 | 6.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 617 | 3,320 | 18.6% | |
Other income | Rs m | 0 | 10 | 2.1% | |
Total revenues | Rs m | 618 | 3,330 | 18.5% | |
Gross profit | Rs m | 94 | 224 | 42.0% | |
Depreciation | Rs m | 8 | 27 | 30.1% | |
Interest | Rs m | 12 | 75 | 16.0% | |
Profit before tax | Rs m | 74 | 131 | 56.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 58 | 2.5% | |
Profit after tax | Rs m | 72 | 74 | 98.4% | |
Gross profit margin | % | 15.2 | 6.7 | 225.7% | |
Effective tax rate | % | 2.0 | 44.0 | 4.5% | |
Net profit margin | % | 11.7 | 2.2 | 528.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 599 | 1,966 | 30.5% | |
Current liabilities | Rs m | 123 | 1,277 | 9.6% | |
Net working cap to sales | % | 77.1 | 20.8 | 371.6% | |
Current ratio | x | 4.9 | 1.5 | 316.6% | |
Inventory Days | Days | 1 | 49 | 2.8% | |
Debtors Days | Days | 146,261,410 | 863 | 16,955,335.7% | |
Net fixed assets | Rs m | 90 | 560 | 16.0% | |
Share capital | Rs m | 100 | 55 | 182.0% | |
"Free" reserves | Rs m | 445 | 1,100 | 40.4% | |
Net worth | Rs m | 545 | 1,155 | 47.2% | |
Long term debt | Rs m | 17 | 67 | 25.6% | |
Total assets | Rs m | 689 | 2,526 | 27.3% | |
Interest coverage | x | 7.2 | 2.7 | 260.1% | |
Debt to equity ratio | x | 0 | 0.1 | 54.2% | |
Sales to assets ratio | x | 0.9 | 1.3 | 68.2% | |
Return on assets | % | 12.3 | 5.9 | 208.2% | |
Return on equity | % | 13.3 | 6.4 | 208.5% | |
Return on capital | % | 15.3 | 16.9 | 90.5% | |
Exports to sales | % | 0 | 47.3 | 0.0% | |
Imports to sales | % | 0 | 0.1 | 0.0% | |
Exports (fob) | Rs m | NA | 1,570 | 0.0% | |
Imports (cif) | Rs m | NA | 5 | 0.0% | |
Fx inflow | Rs m | 0 | 1,570 | 0.0% | |
Fx outflow | Rs m | 0 | 14 | 0.0% | |
Net fx | Rs m | 0 | 1,556 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 5 | 176 | 3.0% | |
From Investments | Rs m | -67 | -89 | 75.2% | |
From Financial Activity | Rs m | 63 | -99 | -63.5% | |
Net Cashflow | Rs m | 1 | -12 | -11.8% |
Indian Promoters | % | 70.2 | 74.7 | 93.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.8 | 25.3 | 118.0% | |
Shareholders | 1,166 | 21 | 5,552.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO US BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO US BIO-TECH | STG INDIA. |
---|---|---|
1-Day | 8.77% | 0.00% |
1-Month | 26.17% | 0.00% |
1-Year | 113.64% | 195.01% |
3-Year CAGR | 152.58% | 117.80% |
5-Year CAGR | 42.16% | 61.68% |
* Compound Annual Growth Rate
Here are more details on the INDO US BIO-TECH share price and the STG INDIA. share price.
Moving on to shareholding structures...
The promoters of INDO US BIO-TECH hold a 70.2% stake in the company. In case of STG INDIA. the stake stands at 74.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO US BIO-TECH and the shareholding pattern of STG INDIA..
Finally, a word on dividends...
In the most recent financial year, INDO US BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
STG INDIA. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of INDO US BIO-TECH, and the dividend history of STG INDIA..
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.